Nucana (NCNA) news
Recent news
Nucana appoints Ian Webster as chief financial officer
NuCana plc has appointed Ian Webster as its interim Chief Financial Officer (CFO), effective immediately . Webster brings over two decades of financial expertise, including more than ten years in senior roles within the biopharmaceutical industry. Prior to joining NuCana in 2019, he served as Group…
AInvest Wire · Jun 1, 2026ImportantNucana shares up 85% premarket after Co. presents encouraging data on NUC-7738
Nucana shares up 85% premarket after Co. presents encouraging data on NUC-7738 NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company specializing in the development of medicines for cancer patients, experienced a notable surge in its share price of 85% premarket on August 15, 2024…
AInvest Wire · Sep 16, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.